PH21162A - Pyridazine derivative amino-substituted in the 3-position and pharmaceutical composition containing them - Google Patents

Pyridazine derivative amino-substituted in the 3-position and pharmaceutical composition containing them

Info

Publication number
PH21162A
PH21162A PH30135A PH30135A PH21162A PH 21162 A PH21162 A PH 21162A PH 30135 A PH30135 A PH 30135A PH 30135 A PH30135 A PH 30135A PH 21162 A PH21162 A PH 21162A
Authority
PH
Philippines
Prior art keywords
substituted
pharmaceutical composition
composition containing
pyridazine derivative
derivative amino
Prior art date
Application number
PH30135A
Other languages
English (en)
Inventor
Chambon Jean-Pierre
Biziere Kathleen
Wermuth Camille-Georges
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PH21162A publication Critical patent/PH21162A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH30135A 1983-01-27 1984-01-20 Pyridazine derivative amino-substituted in the 3-position and pharmaceutical composition containing them PH21162A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
PH21162A true PH21162A (en) 1987-08-05

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
PH30135A PH21162A (en) 1983-01-27 1984-01-20 Pyridazine derivative amino-substituted in the 3-position and pharmaceutical composition containing them

Country Status (27)

Country Link
US (1) US4721711A (es)
EP (1) EP0117779B1 (es)
JP (1) JPS59141564A (es)
KR (1) KR910000638B1 (es)
AR (1) AR240045A1 (es)
AT (1) ATE48417T1 (es)
AU (2) AU2372984A (es)
CA (1) CA1238637A (es)
DD (1) DD220026A5 (es)
DE (1) DE3480653D1 (es)
DK (1) DK162985C (es)
ES (1) ES8500243A1 (es)
FI (1) FI78691C (es)
FR (1) FR2540113A1 (es)
HU (1) HU193890B (es)
IE (1) IE57054B1 (es)
IL (1) IL70756A (es)
MA (1) MA20018A1 (es)
NO (1) NO840313L (es)
NZ (1) NZ206945A (es)
OA (1) OA07644A (es)
PH (1) PH21162A (es)
PL (1) PL142340B1 (es)
PT (1) PT77993B (es)
SG (1) SG93690G (es)
YU (1) YU14284A (es)
ZA (1) ZA84502B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern PROTEIN KINASE ANTI-INFLAMMATORY AND INHIBITOR COMPOSITION AND METHOD OF USE
EP1812007B1 (en) * 2004-11-02 2011-09-07 Northwestern University Pyridazine compounds and methods
CN101087766B (zh) * 2004-11-02 2011-09-07 西北大学 哒嗪化合物、组合物和方法
EP2015750A2 (en) * 2006-04-28 2009-01-21 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
CA2650704A1 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
US20090325973A1 (en) * 2006-04-28 2009-12-31 Watterson D Martin Formulations containing pyridazine compounds
US8283351B2 (en) * 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
WO2009131951A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
EP2341776A4 (en) * 2008-09-19 2012-05-30 Inst Oneworld Health COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING IMIDAZOL AND TRIAZOL DERIVATIVES
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
ES529081A0 (es) 1984-10-01
ZA84502B (en) 1984-09-26
EP0117779B1 (fr) 1989-12-06
AU2372984A (en) 1984-08-02
PT77993B (fr) 1986-04-10
NZ206945A (en) 1987-07-31
FR2540113B1 (es) 1985-05-17
FI78691B (fi) 1989-05-31
NO840313L (no) 1984-07-30
CA1238637A (en) 1988-06-28
FI840323A0 (fi) 1984-01-26
IE57054B1 (en) 1992-04-08
EP0117779A1 (fr) 1984-09-05
SG93690G (en) 1991-01-18
DD220026A5 (de) 1985-03-20
OA07644A (fr) 1985-05-23
MA20018A1 (fr) 1984-10-01
ATE48417T1 (de) 1989-12-15
ES8500243A1 (es) 1984-10-01
PL245931A1 (en) 1985-07-16
DK162985B (da) 1992-01-06
PL142340B1 (en) 1987-10-31
AU2142188A (en) 1989-03-16
DK162985C (da) 1992-06-01
JPS59141564A (ja) 1984-08-14
FI78691C (fi) 1989-09-11
KR910000638B1 (ko) 1991-01-31
DE3480653D1 (de) 1990-01-11
PT77993A (fr) 1984-02-01
IE840149L (en) 1984-07-27
AR240045A1 (es) 1990-01-31
FR2540113A1 (fr) 1984-08-03
KR840007586A (ko) 1984-12-08
DK38984D0 (da) 1984-01-27
IL70756A (en) 1987-03-31
AU652118B2 (en) 1994-08-18
FI840323A (fi) 1984-07-28
US4721711A (en) 1988-01-26
HU193890B (en) 1987-12-28
DK38984A (da) 1984-07-28
YU14284A (en) 1986-12-31
IL70756A0 (en) 1984-04-30

Similar Documents

Publication Publication Date Title
PH21162A (en) Pyridazine derivative amino-substituted in the 3-position and pharmaceutical composition containing them
NZ208959A (en) Insulin derivatives and pharmaceutical compositions
IL72028A0 (en) Aminomethyl-oxooxazolidinylbenzene derivatives and pharmaceutical compositions containing them
IL72566A (en) Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same
EP0138421A3 (en) Hydroxypyridinone derivatives and pharmaceutical compositions containing them
DE3470737D1 (en) 2-aminonitropyridine derivatives and process for the preparation thereof
PH19849A (en) Steroids and their pharmaceutical composition
PH22334A (en) Cephalosporin derivatives and pharmaceutical composition containing same
ZA848128B (en) 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives,their preparation and therapeutic compositions containing the same
NZ210135A (en) 2-pyridylmethyl-thio and sulphinyl-benzimidazole derivatives
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
IL70755A0 (en) Pyridazine derivatives,their preparation and pharmaceutical compositions containing them
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
GB2135879B (en) Pharmaceutical preparations with uniform elution properties
NZ210671A (en) Ortho-condensed pyrrole derivatives and pharmaceutical compositions
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
NZ208694A (en) Rooperol derivatives and pharmaceutical compositions
DE3473444D1 (en) Acylindole derivatives and pharmaceutical compositions containing them
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
IL73224A (en) 2-dioxacycloalkylthiopenem derivatives and pharmaceutical compositions containing them
GB2146329B (en) Naphthalenylimidazopyridine and derivatives and their preparation
PH19896A (en) 4-phenyl-tetrahydro-furano-pyridine and pharmaceutical compositions containing them
NZ207806A (en) Benzothienyl-cephalosporin derivatives and pharmaceutical compositions
DE3460769D1 (en) Improvements in supports for structures and structures incorporating such supports
DE3463383D1 (en) 4-alkylindolonaphthyridines and pharmaceutical compositions containing them